Report Overview
Report Summary
The global Lyophilized IVIG market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Lyophilized IVIG market based on company, product type, end user and key regions.
This report studies the global market size of Lyophilized IVIG in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lyophilized IVIG in these regions.
This research report categorizes the global Lyophilized IVIG market by top players/brands, region, type and end user. This report also studies the global Lyophilized IVIG market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market size by Product
2.5g
1.25g
Market size by End User
Immunodeficiency
Autoimmune Disease
Acute Infection
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Lyophilized IVIG market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Lyophilized IVIG market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Lyophilized IVIG companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Lyophilized IVIG submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Lyophilized IVIG are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Lyophilized IVIG market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Lyophilized IVIG Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Lyophilized IVIG Market Size Growth Rate by Product
1.4.2 2.5g
1.4.3 1.25g
1.5 Market by End User
1.5.1 Global Lyophilized IVIG Market Size Growth Rate by End User
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Lyophilized IVIG Market Size
2.1.1 Global Lyophilized IVIG Revenue 2017-2027
2.1.2 Global Lyophilized IVIG Sales 2017-2027
2.2 Lyophilized IVIG Growth Rate by Regions
2.2.1 Global Lyophilized IVIG Sales by Regions
2.2.2 Global Lyophilized IVIG Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Lyophilized IVIG Sales by Manufacturers
3.1.1 Lyophilized IVIG Sales by Manufacturers
3.1.2 Lyophilized IVIG Sales Market Share by Manufacturers
3.1.3 Global Lyophilized IVIG Market Concentration Ratio (CR5 and HHI)
3.2 Lyophilized IVIG Revenue by Manufacturers
3.2.1 Lyophilized IVIG Revenue by Manufacturers (2017-2020)
3.2.2 Lyophilized IVIG Revenue Share by Manufacturers (2017-2020)
3.3 Lyophilized IVIG Price by Manufacturers
3.4 Lyophilized IVIG Manufacturing Base Distribution, Product Types
3.4.1 Lyophilized IVIG Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lyophilized IVIG Product Type
3.4.3 Date of International Manufacturers Enter into Lyophilized IVIG Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Lyophilized IVIG Sales by Product
4.2 Global Lyophilized IVIG Revenue by Product
4.3 Lyophilized IVIG Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Lyophilized IVIG Breakdown Data by End User
6 North America
6.1 North America Lyophilized IVIG by Countries
6.1.1 North America Lyophilized IVIG Sales by Countries
6.1.2 North America Lyophilized IVIG Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Lyophilized IVIG by Product
6.3 North America Lyophilized IVIG by End User
7 Europe
7.1 Europe Lyophilized IVIG by Countries
7.1.1 Europe Lyophilized IVIG Sales by Countries
7.1.2 Europe Lyophilized IVIG Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lyophilized IVIG by Product
7.3 Europe Lyophilized IVIG by End User
8 Asia Pacific
8.1 Asia Pacific Lyophilized IVIG by Countries
8.1.1 Asia Pacific Lyophilized IVIG Sales by Countries
8.1.2 Asia Pacific Lyophilized IVIG Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Lyophilized IVIG by Product
8.3 Asia Pacific Lyophilized IVIG by End User
9 Central & South America
9.1 Central & South America Lyophilized IVIG by Countries
9.1.1 Central & South America Lyophilized IVIG Sales by Countries
9.1.2 Central & South America Lyophilized IVIG Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Lyophilized IVIG by Product
9.3 Central & South America Lyophilized IVIG by End User
10 Middle East and Africa
10.1 Middle East and Africa Lyophilized IVIG by Countries
10.1.1 Middle East and Africa Lyophilized IVIG Sales by Countries
10.1.2 Middle East and Africa Lyophilized IVIG Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Lyophilized IVIG by Product
10.3 Middle East and Africa Lyophilized IVIG by End User
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Company Business Overview
11.1.3 Baxter Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Baxter Lyophilized IVIG Products Offered
11.1.5 Baxter Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Company Business Overview
11.2.3 Grifols Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Grifols Lyophilized IVIG Products Offered
11.2.5 Grifols Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 Company Business Overview
11.3.3 CSL Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.3.4 CSL Lyophilized IVIG Products Offered
11.3.5 CSL Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Company Business Overview
11.4.3 Octapharma Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Octapharma Lyophilized IVIG Products Offered
11.4.5 Octapharma Recent Development
11.5 Biotest
11.5.1 Biotest Company Details
11.5.2 Company Business Overview
11.5.3 Biotest Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Biotest Lyophilized IVIG Products Offered
11.5.5 Biotest Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Details
11.6.2 Company Business Overview
11.6.3 Kedrion Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Kedrion Lyophilized IVIG Products Offered
11.6.5 Kedrion Recent Development
11.7 Hualan Bio
11.7.1 Hualan Bio Company Details
11.7.2 Company Business Overview
11.7.3 Hualan Bio Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Hualan Bio Lyophilized IVIG Products Offered
11.7.5 Hualan Bio Recent Development
11.8 CNBG
11.8.1 CNBG Company Details
11.8.2 Company Business Overview
11.8.3 CNBG Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.8.4 CNBG Lyophilized IVIG Products Offered
11.8.5 CNBG Recent Development
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Details
11.9.2 Company Business Overview
11.9.3 Shanghai RAAS Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Shanghai RAAS Lyophilized IVIG Products Offered
11.9.5 Shanghai RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 Company Business Overview
11.10.3 CBPO Lyophilized IVIG Sales, Revenue and Gross Margin (2017-2020)
11.10.4 CBPO Lyophilized IVIG Products Offered
11.10.5 CBPO Recent Development
11.11 LFB Group
11.12 BPL
11.13 Sichuan Yuanda Shuyang
12 Future Forecast
12.1 Lyophilized IVIG Market Forecast by Regions
12.1.1 Global Lyophilized IVIG Sales Forecast by Regions 2021-2027
12.1.2 Global Lyophilized IVIG Revenue Forecast by Regions 2021-2027
12.2 Lyophilized IVIG Market Forecast by Product
12.2.1 Global Lyophilized IVIG Sales Forecast by Product 2021-2027
12.2.2 Global Lyophilized IVIG Revenue Forecast by Product 2021-2027
12.3 Lyophilized IVIG Market Forecast by End User
12.4 North America Lyophilized IVIG Forecast
12.5 Europe Lyophilized IVIG Forecast
12.6 Asia Pacific Lyophilized IVIG Forecast
12.7 Central & South America Lyophilized IVIG Forecast
12.8 Middle East and Africa Lyophilized IVIG Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Lyophilized IVIG Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer